These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17690031)

  • 1. Recombinant anti-HBsAg Fab blocks hepatitis B virus infection after orthotopic liver transplantation.
    Pan T; Tang L; Yuan J; Gong NQ; Wang DW; Chen DX; Guo H; Chen ZS
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):370-5. PubMed ID: 17690031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
    Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach of prophylaxis to HBV recurrence after liver transplantation.
    Pan T; Cai M; Tang L; Zhou LQ; Li BJ; Zhu T; Li HZ; Li SY; Xiao X; Chen ZS
    Virology; 2008 Dec; 382(1):1-9. PubMed ID: 18945464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique pattern of fibrosing cholestatic hepatitis after liver transplantation.
    Chen JW; Chen DZ; Chen ZM
    Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):33-4. PubMed ID: 14607619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New sensitive tools for hepatitis B virus (HBV) detection in liver transplantation: what will be their impact on the prophylaxis of HBV infection?
    Samuel D; Roque-Afonso AM
    Liver Transpl; 2007 Aug; 13(8):1084-7. PubMed ID: 17663408
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living donor liver transplantation for hepatitis B associated liver diseases: a 10-year experience in a single center.
    Ikegami T; Soejima Y; Ohta R; Taketomi A; Yoshizumi T; Harada N; Kayashima H; Maehara Y
    Hepatogastroenterology; 2008; 55(85):1445-9. PubMed ID: 18795708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.
    Riediger C; Berberat PO; Sauer P; Gotthardt D; Weiss KH; Mehrabi A; Merle U; Stremmel W; Encke J
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii37-viii46. PubMed ID: 17890261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human bone marrow mesenchymal stem cells are resistant to HBV infection during differentiation into hepatocytes in vivo and in vitro.
    Xie C; Zheng YB; Zhu HP; Peng L; Gao ZL
    Cell Biol Int; 2009 Apr; 33(4):493-500. PubMed ID: 19272332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylaxsis against recurrance of hepatitis B virus after liver transplantation].
    Wu JS; Lu SC; Wang ML; Xia RP; Guo QL; Gao DM; Zhang Y; Liu Y; Li N
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):367-9. PubMed ID: 19469177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
    J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F; Loggi E; Chisholm JV; Biselli M; Morelli MC; Cursaro C; Terrault NA; Bernardi M; Bertoletti A; Andreone P; Brander C
    Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice.
    Rauschhuber C; Xu H; Salazar FH; Marion PL; Ehrhardt A
    J Gene Med; 2008 Aug; 10(8):878-89. PubMed ID: 18470951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endonexin II, present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus (HBV) envelope protein.
    Hertogs K; Leenders WP; Depla E; De Bruin WC; Meheus L; Raymackers J; Moshage H; Yap SH
    Virology; 1993 Dec; 197(2):549-57. PubMed ID: 8249278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of occult hepatitis B after removal of the hepatitis B virus-infected liver.
    Ciesek S; Helfritz FA; Lehmann U; Becker T; Strassburg CP; Neipp M; Ciner A; Fytili P; Tillmann HL; Manns MP; Wedemeyer H
    J Infect Dis; 2008 Feb; 197(3):355-60. PubMed ID: 18248299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.
    Qu Z; Liang X; Liu Y; Du J; Liu S; Sun W
    Mol Immunol; 2009 Dec; 47(2-3):283-9. PubMed ID: 19804910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.